We demonstrated elevated expression levels of NCKAP1 in multiple cancer types, including cholangiocarcinoma (CHOL), head and neck squamous cell carcinoma (HNSC), liver hepatocellular carcinoma (LIHC), and stomach adenocarcinoma (STAD). Here, NCKAP1 is linked to head and neck squamous cell carcinoma.